Clark PB - Search Results

1

Reversal of hypermetabolic brown adipose tissue in F-18 FDG PET imaging.

Christensen CR, Clark PB, Morton KA. Christensen CR, et al. Among authors: clark pb. Clin Nucl Med. 2006 Apr;31(4):193-6. doi: 10.1097/01.rlu.0000204199.33136.05. Clin Nucl Med. 2006. PMID: 16550009

2

Predictive value of 18-fluoro-deoxy-glucose-positron emission tomography (18F-FDG-PET) in the identification of responders to chemoradiation therapy for the treatment of locally advanced esophageal cancer.

Levine EA, Farmer MR, Clark P, Mishra G, Ho C, Geisinger KR, Melin SA, Lovato J, Oaks T, Blackstock AW. Levine EA, et al. Ann Surg. 2006 Apr;243(4):472-8. doi: 10.1097/01.sla.0000208430.07050.61. Ann Surg. 2006. PMID: 16552197 Free PMC article. Clinical Trial.

3

Providing optimal preoperative localization for recurrent parathyroid carcinoma: a combined parathyroid scintigraphy and computed tomography approach.

Clark P, Wooldridge T, Kleinpeter K, Perrier N, Lovato J, Morton K. Clark P, et al. Clin Nucl Med. 2004 Nov;29(11):681-4. doi: 10.1097/00003072-200411000-00001. Clin Nucl Med. 2004. PMID: 15483477

4

Brain abnormalities detected on whole-body 18F-FDG PET in cancer patients: spectrum of findings.

Stubbs E, Kraas J, Morton KA, Clark PB. Stubbs E, et al. Among authors: clark pb. AJR Am J Roentgenol. 2007 Mar;188(3):866-73. doi: 10.2214/AJR.06.0109. AJR Am J Roentgenol. 2007. PMID: 17312080 Review.

5

The scintigraphic appearance of subcapsular parathyroid adenomas.

Kraas J, Clark PB, Perrier ND, Morton KA. Kraas J, et al. Among authors: clark pb. Clin Nucl Med. 2005 Apr;30(4):213-7. doi: 10.1097/01.rlu.0000155982.79457.2b. Clin Nucl Med. 2005. PMID: 15764873 Clinical Trial.

6

Nonneoplastic diseases in the chest showing increased activity on FDG PET.

Kavanagh PV, Stevenson AW, Chen MY, Clark PB. Kavanagh PV, et al. Among authors: clark pb. AJR Am J Roentgenol. 2004 Oct;183(4):1133-41. doi: 10.2214/ajr.183.4.1831133. AJR Am J Roentgenol. 2004. PMID: 15385320 Review. No abstract available.

7

Enhanced scintigraphic protocol required for optimal preoperative localization before targeted minimally invasive parathyroidectomy.

Clark PB, Case D, Watson NE Jr, Perrier ND, Morton KA. Clark PB, et al. Clin Nucl Med. 2003 Dec;28(12):955-60. doi: 10.1097/01.rlu.0000099860.30947.8a. Clin Nucl Med. 2003. PMID: 14663315

8

Neurofunctional imaging of the pancreas utilizing the cholinergic PET radioligand [18F]4-fluorobenzyltrozamicol.

Clark PB, Gage HD, Brown-Proctor C, Buchheimer N, Calles-Escandon J, Mach RH, Morton KA. Clark PB, et al. Eur J Nucl Med Mol Imaging. 2004 Feb;31(2):258-60. doi: 10.1007/s00259-003-1350-7. Eur J Nucl Med Mol Imaging. 2004. PMID: 15129709

9

Outcomes of patients with esophageal cancer staged with [¹⁸F]fluorodeoxyglucose positron emission tomography (FDG-PET): can postchemoradiotherapy FDG-PET predict the utility of resection?

Monjazeb AM, Riedlinger G, Aklilu M, Geisinger KR, Mishra G, Isom S, Clark P, Levine EA, Blackstock AW. Monjazeb AM, et al. J Clin Oncol. 2010 Nov 1;28(31):4714-21. doi: 10.1200/JCO.2010.30.7702. Epub 2010 Sep 27. J Clin Oncol. 2010. PMID: 20876421 Free PMC article.

10

A prospective evaluation of the impact of 18-F-fluoro-deoxy-D-glucose positron emission tomography staging on survival for patients with locally advanced esophageal cancer.

Blackstock AW, Farmer MR, Lovato J, Mishra G, Melin SA, Oaks T, Aklilu M, Clark PB, Levine EA. Blackstock AW, et al. Among authors: clark pb. Int J Radiat Oncol Biol Phys. 2006 Feb 1;64(2):455-60. doi: 10.1016/j.ijrobp.2005.07.959. Epub 2005 Oct 5. Int J Radiat Oncol Biol Phys. 2006. PMID: 16213103 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results